CMF - Center for Molecular Fingerprinting
Marko Madaras serves as the Chief Operating Officer at CMF - Center for Molecular Fingerprinting since April 2019, following a tenure as an Investment Banker at MFS Capital Advisors from August 2017 to July 2018. Prior experience includes a role as a Graduate Assistant at Nicolais School of Business | Wagner College from July 2016 to June 2018 and as a Division I Student Athlete at Pepperdine University, where Marko was the team captain of the water polo team, participating in over 60 NCAA Division I games and earning accolades such as NCAA All American Honorable Mention in 2013 and Masters Nationals First Team All American in 2015. Marko holds a Bachelor’s Degree in Economics from Pepperdine University and an M.B.A. in Finance from Nicolais School of Business | Wagner College.
This person is not in any teams
This person is not in any offices
CMF - Center for Molecular Fingerprinting
Our goal is to develop, validate and establish a simple method for the ‘molecular fingerprinting’ of blood samples, based on the use of an innovative, cutting-edge, ultrafast laser technology. At present, many types of cancer can only be reliably detected by careful examination of multiple tissue samples (biopsies). Our new method dispenses with the need for biopsies, as it is designed to detect the changes in the chemical composition of the blood that reveal the presence of cancer cells in the body, i.e. the cancer’s molecular fingerprint. Our efforts are primarily focused on the development of oncological diagnostics for the most common malignancies: cancers of the breast, lung and prostate gland.